• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

189.76 +1.64 (+0.87%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,210,436
Open 186.01
Bid (Size) 188.00 (100)
Ask (Size) 194.50 (300)
Prev. Close 188.12
Today's Range 184.37 - 193.50
52wk Range 47.28 - 224.31
Shares Outstanding 106,313,250
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? ↗
September 24, 2026
Revolution Medicines' stock is up 330% in a year on drug development progress; you may want to spread your bets with Royalty Pharma instead. 
Via The Motley Fool
News headline image
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 18, 2026
Axsome is generating revenue from approved drugs but missing estimates and widening losses. Revolution Medicines just changed the standard of care for one of the deadliest cancers in existence. 
Via The Motley Fool

Performance

52-Week Range 15.4% below 52-week high
189.76
47.2852W Low 224.3152W High
1 Week 9.8% below 1-week high
180.491W Low 210.271W High

Revolution Medicines, Inc. - Common Stock (RVMD) traded between $47.28 and $224.31 over the past 52 weeks and last traded at $189.76, 15.4% below its 52-week high. Over the past week it ranged between $180.49 and $210.27.

Past 12 Months
-8.6%
-8.6%
+1.5%
+96.8%
+140.1%
+298.5%
1W -$17.92
1M -$17.92
3M +$2.88
6M +$93.33
YTD +$110.74
1Y +$142.14

RVMD was +298.5% over the past year, +96.8% over six months, +140.1% year to date, -8.6% in the last week.

12 Months vs Market
RVMD
+298.5%
DIA
+11.4%
SPY
+16.0%
QQQ
+23.0%
IWM
+13.8%

Over the past 12 months RVMD returned +298.5% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +23.0% and IWM (Russell 2000) +13.8%.

Volume & Liquidity 1.14× 3-mo avg
Today 2,210,436 3-mo avg 1.9M
1W
2.3M
1M
2.2M
3M
1.9M
6M
2.7M
YTD
2.9M
1Y
2.7M

RVMD most recently traded 2,210,436 shares against a 3-month average daily volume of 1.9M.

More News

Read More
News headline image
Revolution Medicines Just Hit a Major Milestone. Is the Stock a Buy? ↗
September 17, 2026
Via The Motley Fool
Revolution Medicines (NASDAQ:RVMD) Misses Q2 Estimates, Yet FDA Accepts Daraxonrasib Application ↗
August 05, 2026
Via Chartmill
Revolution Medicines (NASDAQ:RVMD) Flashes Strong Technical Breakout Setup ↗
July 30, 2026
Via Chartmill
News headline image
MarketBeat Week in Review – 09/07 - 09/11 ↗
September 12, 2026
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026? ↗
September 11, 2026
Via The Motley Fool
News headline image
Revolution Medicines Got Its Breakthrough—What Moves It Next? ↗
September 04, 2026
Via MarketBeat
News headline image
$100 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today ↗
September 04, 2026
Via Benzinga
News headline image
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer ↗
August 28, 2026
Via MarketBeat
News headline image
Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X? ↗
August 28, 2026
Via The Motley Fool
News headline image
Here's How Much $1000 Invested In Revolution Medicines 5 Years Ago Would Be Worth Today ↗
August 26, 2026
Via Benzinga
News headline image
Billionaire Stanley Druckenmiller Continues to Load Up on Revolution Medicines. Does He Know Something Wall Street Doesn't? ↗
August 25, 2026
Via The Motley Fool
News headline image
GLP-1 Drugs Are Huge. These 2 Stocks Are Tapping Into an Even Bigger Opportunity ↗
August 24, 2026
Via The Motley Fool
News headline image
Meet the Vanguard ETF That's Crushing the S&P 500 and Nasdaq-100 Despite Not Owning Micron, Sandisk, or Any of the "Magnificent Seven" Stocks ↗
August 18, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
Revolution Medicines (RVMD) Q2 2026 Earnings Call Transcript ↗
August 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Here’s How Much You Would Have Made Owning Revolution Medicines Stock In The Last 5 Years ↗
August 07, 2026
Via Benzinga
News headline image
Revolution Medicines Q2 Earnings Call Highlights ↗
August 06, 2026
Via MarketBeat
Topics Earnings
News headline image
Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy? ↗
August 03, 2026
Via The Motley Fool
News headline image
Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock ↗
August 02, 2026
Via The Motley Fool
News headline image
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now ↗
July 29, 2026
Via The Motley Fool
News headline image
This Stock Has Skyrocketed 125% in 2026 -- and Billionaire Stanley Druckenmiller Is Loading Up on It ↗
July 17, 2026
Via The Motley Fool
News headline image
Better Growth Buy: Axsome vs Revolution Medicines ↗
July 09, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
July 07, 2026
From Revolution Medicines, Inc.
Via GlobeNewswire
News headline image
These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More ↗
July 06, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks

Frequently Asked Questions

Is Revolution Medicines, Inc. - Common Stock publicly traded?
Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
What exchange does Revolution Medicines, Inc. - Common Stock trade on?
Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
What is the current price of Revolution Medicines, Inc. - Common Stock?
The current price of Revolution Medicines, Inc. - Common Stock is 189.76
When was Revolution Medicines, Inc. - Common Stock last traded?
The last trade of Revolution Medicines, Inc. - Common Stock was at 10/09/26 04:00 PM ET
What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
The market capitalization of Revolution Medicines, Inc. - Common Stock is 20.17B
How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
Revolution Medicines, Inc. - Common Stock has 20B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap